Migdal Insurance and Financial Holdings (MGDL) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
3 Nov, 2026Executive summary
9M 2024 total comprehensive income was NIS 494m versus NIS 85m; Q3 income was NIS 285m versus a NIS 14m loss.
Underwriting profit rose 55% to NIS 695m in 9M, with growth across business lines; progress toward 2027 strategic targets was ahead of schedule.
Financial highlights
9M underwriting profit was NIS 695m versus NIS 448m; Q3 was NIS 219m versus NIS 160m, up 37%.
Gross premiums and contributions reached NIS 22.2bn in 9M, up 13% YoY; Q3 totaled NIS 7.7bn, also up 13%.
Q3 excess investment profit was NIS 181m versus a NIS 642m loss; the 9M investment loss narrowed by NIS 343m YoY.
9M results included special effects that increased pretax profit by NIS 733m; a NIS 633m one-time life-insurance gain was a major contributor.
Total revenue was NIS 25.218bn for 9M versus NIS 20.940bn; net income was NIS 588.7m versus NIS 224.1m.
Outlook and guidance
Management expected improvement trends to continue and reported progress ahead of the strategic plan’s 2027 targets.
First use of the stochastic model in the Dec. 31, 2024 solvency calculation was estimated to increase the ratio by 9 percentage points without transition measures and 11 points with them, based on June 30, 2024.
Preliminary IFRS 17/9 transition estimates put opening equity at NIS 6–6.5bn for the insurer and NIS 6.5–7bn at the holding level; estimates remain subject to revision.
Latest events from Migdal Insurance and Financial Holdings
- Actuarial gains and stronger underwriting lifted H1 earnings despite investment losses.MGDL
Q2 2024 - Underwriting and asset growth offset lower profit and variable-fee market headwinds.MGDL
Q1 2024 - FY2024 profit nearly doubled as underwriting gains and resumed fees lifted results.MGDL
Q4 2024 - Market losses drove a FY2022 comprehensive loss despite premium growth and rate-driven liability relief.MGDL
Q4 2022 - Rate-driven reserve releases lifted profit despite investment losses and weak auto underwriting.MGDL
Q1 2022 - Market losses drove an ₪855.3m 9M comprehensive loss despite premium growth.MGDL
Q3 2022 - H1 net income rose, but market losses and longevity assumptions drove a ₪712m comprehensive loss.MGDL
Q2 2022 - H1 results rebounded, while Q2 losses reflected a life-policy charge and underwriting pressures.MGDL
Q2 2023 - Profit rebounded to NIS 553m in 2023; 2027 targets include ~NIS 1bn profit and ~12% ROE.MGDL
Q4 2023